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abstract
CONTEXT: One of the major current challenges related to juvenile
idiopathic inflammatory myopathy is the search for highly sensitive
and specific non-invasive methods for diagnosis as well as for fol-
low-up.
OBJECTIVES: The aim of our study was to describe typical magnetic
resonance imaging findings and to investigate the usefulness of this
method in detecting active muscle disease in juvenile dermatomyosi-
tis and juvenile systemic lupus erythematosus patients.
DESIGN:  Transverse study, blinded assessment.
SETTING: University referral unit (Pediatric Rheumatology section,
Department of Pediatrics, Universidade Federal de São Paulo / Escola
Paulista de Medicina).
SAMPLE: Thirteen patients (9 girls) with dermatomyositis, as well as
13 patients (12 girls) with juvenile systemic lupus erythematosus
and 10 normal children (5 girls), were enrolled in the study.
MAIN MEASUREMENTS: Qualitative and quantitative analyses of
gluteus maximus, quadriceps, adductors and flexors were performed
and evaluated by two radiologists, blinded to all clinical informa-
tion. Spin-echo in T1, DP, T2 and IR was used in all MRI images.
RESULTS: The different muscle groups presented non-uniform involve-
ment in the patients. The patients with dermatomyositis presented
acute and chronic muscular alterations, while those with lupus pre-
sented only chronic myopathy, especially atrophy. In the dermato-
myositis group, the major alterations were found in the gluteus and
flexor regions (signal intensity and fat replacement). The signal in-
tensity was increased in all acute myopathies.
CONCLUSION: The qualitative and quantitative resonance analyses
are useful in detecting clinically active disease in patients with der-
matomyositis.
KEY WORDS: Juvenile dermatomyositis. Juvenile systemic lupus
erythematosus. Muscle involvement. Magnetic resonance imaging.
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INTRODUCTION
Idiopathic inflammatory myopathy syndrome is
constituted by a heterogeneous group of diseases, of
unknown etiology, that have in common an inflam-
matory muscle process.
It is characterized by proximal muscular weak-
ness, elevation of serum enzymes related mainly to
striated musculature, electromyograph alterations,
presence of mononuclear infiltrate in muscles and ab-
sence of recognizable etiology.1 This group of diseases
presents a large range of histopathological findings,
response to treatment and clinical evolution.
The principal representatives of idiopathic in-
flammatory myopathies are dermatomyositis, poly-
myositis and inclusion body myositis. Juvenile der-
matomyositis is the most important during infancy,
as it occurs most frequently and presents the most
severe muscular inflammation.  There are also myo-
pathies associated with other connective tissue dis-
eases, especially juvenile systemic lupus erythemato-
sus, scleroderma and juvenile rheumatoid arthritis.
One of the major current challenges related to
idiopathic inflammatory myopathies is the search for
highly sensitive and specific non-invasive methods for
diagnosis as well as for treatment follow-up. Among
the image diagnosis methods, magnetic resonance
imaging (MRI) has shown itself to be one of the best
techniques for this purpose and for muscle skeleton
disease follow-up.2,3
In 1987, Kaufman et al,4 in a study carried out with
dermatomyositis patients, observed a correlation be-
tween inflammatory muscle activity and some param-
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eters analyzed by resonance. In later studies, undertaken
mainly with adult patients, the usefulness of this method
in the diagnosis of acute and chronic inflammatory
muscle diseases was observed.5-7 However, although id-
iopathic inflammatory myopathies in childhood present
their own characteristics, studies using MRI for muscu-
lar evaluation are not common.8-10 This fact motivated
us to study resonance alterations in patients with juve-
nile dermatomyositis and juvenile systemic lupus erythe-
matosus, and to correlate the findings quantitatively and
qualitatively with the presence of inflammatory activity.
METHODS
The procedures that follow were in accordance
with the ethical standards of the committee respon-
sible for human experimentation and with the Helsinki
Declaration of 1975, as revised in 1983.
Design
Transverse study, blinded assessment.
Setting
Academic referral unit (Pediatric Rheumatology
section, Department of Pediatrics, Universidade Fed-
eral de São Paulo / Escola Paulista de Medicina).
Sample
Twenty six patients divided into 2 groups were
evaluated over a period of 2 years: 13 with dermato-
myositis (9 girls) diagnosed according to the Bohan and
Peter (1975) criteria,11 with ages ranging from 5.6 to 16.6
years (mean of 11.7 years); 13 patients with juvenile
systemic lupus erythematosus (12 girls) according to
the American College of Rheumatology criteria,11 with
ages ranging from 9.3 to 16.7 years (mean 13.6).  The
mean disease duration was 4.5 years (range 1.5 to 13.6)
for dermatomyositis and 3.7 years (range 0.4 to 8.6) for
lupus patients. We also calculated the mean daily cor-
ticosteroid dose for each patient during the last 6
months and correlated it with the MRI findings. The
control group consisted of 10 healthy children and ado-
lescents (5 girls), with ages ranging from 5.0 to 16.0 years
(mean of 11.6 years), free from any disease.
Diagnostic Procedures
Clinical Evaluation. The characterization of inflam-
matory activity in the dermatomyositis group was
based on the clinical parameters of muscular strength
and the presence of altered muscle enzymes, particu-
larly the creatine kinase, aspartate aminotransferase,
aldolase and lactic dehydrogenase. For lupus patients,
the Systemic Lupus Erythematosus Disease Activity
Index (SLEDAI) and the following scores were used:13
mild disease activity (score 1 to 9), moderate (score
10 to 19) and  severe (score ≥ 20) disease activity. All
parents gave informed consent for the study, which
had the prior approval of the local ethics committee.
Magnetic Resonance Imaging. To carry out the MRI,
the equipment used was a Philips 1.5-tesla Gyroscan
S15, release 5.6. We performed T1-weighted and T2-
weighted images with spin-echo (SE) sequences and
fat suppression technique, with an inversion recovery
Table 1 - Qualitative Analysis -
 score of each parameter analyzed
                         Score
Findings 0 1
↑ muscular signal intensity ≤ 50% > 50%
↑ biochemical shift No Yes
Perimuscular edema No Yes
↑ signal intensity of subcutaneous fat No Yes
Muscular  atrophy ≥ 0.75 < 0.75
Muscular fat replacement ≤ 50% > 50%
Table 2 - Patients with dermatomyositis, according to the number
of muscle groups affected in the qualitative analysis
Patient ↑muscular ↑biochemical perimuscular ↑subcutaneous muscular muscular fat
signal shift edema fat signal  atrophy replacement
intensity intensity
1 0 2 0 0 1 1
2 2 2 1 2 1 0
3 0 0 1 0 0 0
4 0 1 1 1 1 0
5 1 1 0 0 1 2
6 0 0 1 0 1 1
7 0 1 0 0 1 0
8 4 4 1 0 1 4
9 0 0 0 0 1 0
10 0 0 0 0 0 0
11 0 0 0 0 1 0
12 3 4 4 1 1 0
13 1 0 0 2 0 0
Mean 0.84 1.15 0.69 0.46 0.69 0.61
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(IR) sequence. The T1-weighted images were acquired
in the coronal and axial planes: SE, TR/TE of 500-640/
20ms, 2 to 4 acquisitions, 180 X 256 matrix, 10/10 mm
thickness/increase and field of view (FOV) of 350 mm
on the axial and 500 mm on the coronal. The T2 im-
ages were acquired in the axial plane: SE, TR/TE of
2500/90 ms, 1 acquisition, 204 x 256 matrix, 10/10 mm
thickness/increase and FOV of 300 mm. The IR images
were acquired in the axial plane: TR/TE/TI of 1900-2000/
20/160 ms, 2 acquisitions, 180 x 256 matrix, 10/10 mm
and FOV of 300 mm. Each patient and control was
submitted to an MRI exam (total of 36). T1-weighted,
T2-weighted and IR images were acquired. All images
were obtained with the center in the mid-thigh.
Main Measurements
The muscle groups studied were: gluteus maxi-
mus, quadriceps, adductors and flexors. The exams were
evaluated by 2 radiologists who carried out qualitative
and quantitative analysis of the 4 muscle groups by
consensus, with no knowledge of the patient history.
For the qualitative analysis in T2-weighted, T1-weighted
and IR, 6 types of findings were standardized and given
points in accordance with Table 1. The first 4 (signal
intensity, chemical shift, perimuscular edema and sig-
nal intensity of subcutaneous fat) are findings of acute
alterations and were observed on T2-weighted images.
The other 2 parameters were observed on T1-weighted
and IR images.  With this method the maximum pos-
sible score obtainable on evaluation of each patient
was 21 points. A lower score indicated lesser muscular
problems. The analysis of muscular atrophy was made
based on the relationship between the thigh muscle
diameter and the total thigh diameter.
The quantitative analysis was undertaken in T2-
weighted images and the signal intensity of each in-
dividual group of muscles was obtained using a re-
gion of interest (ROI) of 0.5 cm at the midpoint of the
thigh and lower third of the hip. The relationship be-
tween intensities of the muscle/fat signal was calcu-
lated by means of dividing the signal intensity mea-
surements of the muscle groups by the fat measure-
ments. For each muscle group, the mean of the 3 mea-
surements obtained in the region with the strongest
signal of the section being studied was used.
Statistical Methods
The following non-parametric tests were used to
analyze the results: Kruskal-Wallis test, exact Fisher test,
Mann-Whitney test and the Friedman ranked variance
analysis test. In all the tests, the level for the rejection
of the null hypothesis was fixed at 5% (P < 0.05).
RESULTS
Muscular weakness was observed in 9/13 pa-
tients (68%) with dermatomyositis, of whom 6 (46%)
presented elevated muscular enzymes. The neck flexor
muscles were the most affected. Creatine kinase was
the most frequently altered enzyme (83%). Disease
activity was characterized in 46% of patients.
We did not observe any clinical muscle impair-
Figure 1 - Patients with juvenile dermatomyositis, juvenile systemic lupus
erythematosus and controls, according to the total alterations present in
the muscle groups at qualitative analysis.
Figure 2 - Patients with JDM, JSLE and controls, according to thigh
muscle diameter/total thigh diameter (muscle atrophy).
Figure 3 - Relationship between the intensity of the muscle/fat signal in
juvenile dermatomyositis, juvenile systemic lupus erythematosus and
control groups.
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ment or muscular enzyme elevation in patients with
lupus. As regards SLEDAI, 4 patients presented mild
disease activity, 5 moderate and 4 severe disease ac-
tivity.
Magnetic Resonance Imaging
The frequency of alterations observed in the
qualitative analysis was significantly higher in patients
with dermatomyositis when compared to the lupus
patients and controls (Figure 1).  Among the variables
studied, the muscle signal intensity and the chemical
shift presented the most alterations, although there
was no significant statistical difference (Table 2). The
statistical analysis showed a significant association
(P < 0.05) between the presence of acute findings and
the dermatomyositis group. One interesting observa-
tion was the high frequency of chronic alterations in
patients with lupus instead of acute alterations.
In relation to muscular atrophy, the greatest in-
volvement was observed in patients with dermatomyo-
sitis: this was less pronounced in patients with lupus,
and not present in the controls (Figure 2). Quantita-
tive analysis showed greater involvement of gluteus
maximus and quadriceps in dermatomyositis patients
as compared to controls.
In Figure 3 the muscle/fat relationship mean can
be observed for muscle groups in patients with der-
matomyositis, lupus and controls. The correlation
between MRI, muscular weakness and elevation of
muscle enzymes was determined only for patients with
dermatomyositis, as the alterations were not observed
in the lupus group. Regarding muscular weakness, a
statistically significant association with the acute al-
terations was found and a tendency towards an asso-
ciation with the chronic alterations of the qualitative
analysis was found. The patients with dermatomyosi-
tis and more accentuated muscular weakness pre-
sented a higher muscle/fat relationship and therefore
greater involvement in the quantitative analysis (P =
0.008).
The increase in muscle enzymes also showed a
significant correlation with the acute changes observed
in the MRI qualitative analysis (P=0.004). Qualitative
analysis variables only presented a statistically sig-
nificant correlation with the biochemical shift analy-
sis (P < 0.05).
Quantitative analysis showed a statistically sig-
nificant correlation between higher values in the
muscle/fat relationship and the raising of muscle en-
zymes (P = 0.015). In the dermatomyositis group, the
mean daily corticosteroid dose was 0.59 mg (0 to 1.2
mg/kg/day) and higher doses only presented a corre-
lation with the muscle/fat relationship (quantitative
analysis). In the lupus group we did not observe a cor-
relation between the mean corticosteroid dose (0.47
mg/kg/day) and the MRI findings.
DISCUSSION
We evaluated 13 patients with juvenile dermato-
myositis, 13 patients with juvenile systemic lupus
erythematosus and 10 normal children and adoles-
cents, using MRI exams with the spin-echo technique,
with T1-weighted, T2-weighted and IR (fat suppression)
images.  The aim of this study was to correlate the
clinical and laboratory alterations with the MRI find-
ings. The study was performed with 2 types of analy-
sis, the qualitative and the quantitative.
Characterization of disease activity in our der-
matomyositis group was based on changes in muscu-
lar strength associated with the presence of elevated
muscle enzymes, which will be discussed.  As we know,
muscle enzymes do not correlate well with muscular
strength, rashes or muscle biopsy in some patients.14,15
On the other hand muscle weakness, in chronic pa-
tients, may just reflect muscular atrophy and fibrosis
related to continuous or chronic-recurrent inflamma-
tory disease. In spite of all these considerations, we
decided to employ this criterion, since it is widely used
in the literature.4,6,16
Disease activity was diagnosed in 46% of our
patients with dermatomyositis. All lupus patients pre-
sented disease activity ranging from mild to severe,
which was expected, as the group was heterogeneous
in terms of disease duration and type of involve-
ment.17,18 We did not observe clinical muscle involve-
ment (muscle weakness) in these patients, as was
described by other authors.19,20
Different to most studies published in the lit-
erature, which in general use 4 MRI parameters, we
analyzed 6 types of findings for qualitative analysis:
increase in muscle signal intensity, increase of chemi-
cal shift, perimuscular edema, increase in the inten-
sity of the subcutaneous fat signal, muscular atrophy
and muscle fat replacement. The frequency of the 5
qualitative MRI analysis findings (with the exception
of atrophy) in the dermatomyositis group had no sig-
nificant statistical difference, which may indicate that
all the variables could have the same degree of im-
portance. However, we must take into account that our
patients were at different stages of activity.  “Increase
in the signal intensity” was able to detect patients with
greater disease activity, presenting 80% sensibility and
75% specificity. These results are similar to those of
Fujino et al,19 who observed an alteration in signal in-
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tensity in 7 of 8 patients with active dermatomyositis.
The “chemical shift” detected alterations in 7 patients,
6 of whom with disease activity, thereby showing a
sensitivity of 85.7% and a specificity of 83.3% in the
detection of disease activity.
Muscular atrophy and fat replacement are quali-
tative analysis findings associated with chronic muscle
processes. The cause of muscular atrophy in dermato-
myositis is multifactorial and may be due to chronic
inflammation with important muscular impairment,
reduction of physical activity during disease activity and
long term corticotherapy with elevated doses.20 It is
probable that these 3 factors contributed to the pres-
ence of muscular atrophy in 84% (11/13) of the patients
with dermatomyositis. The remaining patients were not
active and were using low doses of corticosteroids.
Due to the small number of findings in patients
with lupus, we did not carry out a statistical analysis.
Nevertheless, it is interesting to note that 41% of the
total qualitative analysis findings occurred in one pa-
tient, who at the time of the exam presented reactiva-
tion of the disease, with intense general manifesta-
tions and moderate disease activity (SLEDAI), al-
though with no alterations in muscle enzymes or mus-
cular strength. Chronic alterations predominated in
lupus patients, represented mainly by muscular atro-
phy.  This finding could be explained by some factors,
such as the reduction in physical activity, prolonged
corticotherapy with high doses, and perhaps the ex-
istence of a subclinical myopathy.
In summary, 92.3% (12/13) with dermatomyosi-
tis presented some degree of involvement in the quali-
tative resonance analysis, whereas the enzyme alter-
ation was observed in 6 (46%). In the study of Park et
al,21 the qualitative analysis alterations were present
in 81.8% of patients, whereas the enzyme alterations
amounted to 27%. These figures suggest that reso-
nance is capable of detecting muscle involvement in
patients with no clinical or enzyme alterations, per-
haps by detecting subclinical disease activity and
muscle scarring involvement. Some studies of patients
1. Plotz PH, Dalakas M, Leff RL, Love AA, Miller FW, Cronin ME.  Current
concepts in idiopathic inflammatory myopathies: polymyositis,
dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
2. Council of Scientific Affairs: Musculoskeletal applications of magnetic
resonance imaging. JAMA 1989;262:2430-7.
3. Collison CH, Sinal SH, Jorizzo JL, Walker FO, Monu JU, Snyder J. Juvenile
dermatomyositis and polymyositis: a follow-up study of long-term
sequelae. South Med J 1998;91:17-22.
4. Kaufman LD, Gruber BL, Gertsman DP, Kaell AT. Preliminary
with disease activity found resonance alterations in
100% of cases.16,22
Quantitative analysis is in general correlated
with acute alterations in muscle involvement or ac-
tive disease.23 In our study we observed significant
differences among dermatomyositis, lupus and con-
trols in 2 muscular groups (gluteus maximus and quad-
riceps). In the study of Hernandez et al,22 the muscle/
fat relationship mean for 4 muscle groups in 4 chil-
dren was evaluated at onset and 6 months after the
start of treatment. These authors observed significant
differences between the muscle/fat relationship mean
for the gluteus maximus, adductors and quadriceps
of patients with dermatomyositis. The difference be-
tween our findings and those of Hernandez et al,22 may
have occurred because of heterogeneous muscle in-
volvement, different degrees of disease activity and
the longer disease duration observed in our patients.
In our study, the muscle/fat relationship mean varied
between 0.42 and 0.46. In the study of Hernandez et
al,22 the mean values at the time of diagnosis were
between 0.76 and 1.17 in the 4 muscle groups. After 6
months of treatment they observed a reduction in
these relationships (0.41 to 0.61). This demonstrates
that the muscle/fat relationship (quantitative analy-
sis) is related to acute processes and that there is a
tendency to normalization of this relationship during
treatment.
CONCLUSIONS
Magnetic resonance imaging is a useful method
in the detection of muscular involvement and in the
follow-up of patients with idiopathic inflammatory
myopathies. It can be used in diverse ways because it
is able to differentiate normal from pathologic mus-
culature, to define acute and chronic muscle alter-
ations and to detect and rank muscle involvement in
relation to disease activity. In addition, it is a non-
invasive, radiation free, painless examination that can
be used repeatedly.
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resumo
CONTEXTO: Um dos maiores desafios relacionados as miopatias
inflamatórias idiopáticas juvenis está na procura de métodos sensíveis
e específicos, porém não invasivos, para o seu diagnóstico e
acompanhamento.
OBJETIVO: Avaliar os achados da ressonância magnética e investigar
a utilidade do método na detecção do comprometimento muscular
em pacientes com dermatomiosite juvenil e lúpus eritematoso
sistêmico juvenil.
TIPO DE ESTUDO: Transversal, simples cego.
LOCAL: Setor de Reumatologia Pediátrica do Departamento de
Pediatria da Universidade Federal de São Paulo / Escola Paulista
de Medicina.
MÉTODOS: Fizeram parte do estudo 13 pacientes (9 meninas) com
dermatomiosite juvenil, 13 pacientes (12 meninas) com lúpus
eritematoso sistêmico juvenil e 10 crianças (5 meninas) normais
como controles. Em todas as imagens da ressonância foi utilizado o
spin-eco em T1, DP, T2 e IR e realizadas as análises qualitativa e
quantitativa dos glúteos máximos, quadríceps, adutores e flexores.
Os exames foram avaliados por dois radiologistas que não tiveram
acesso a qualquer informação sobre os pacientes.
RESULTADOS: Mostraram comprometimento não uniforme dos
diferentes grupos musculares em todos os pacientes. Alterações
agudas e crônicas foram observadas nos pacientes com
dermatomiosite enquanto que naqueles com lúpus foram encontradas
apenas alterações crônicas, especialmente atrofia. As alterações
mais importantes (substituição gordurosa e aumento da intensidade
de sinal) foram observadas nos glúteos e flexores dos pacientes
com dermatomiosite. Aumento da intensidade de sinal esteve presente
em todas as miosites agudas.
CONCLUSÃO: A análise qualitativa e quantitativa da ressonância
magnética é útil para a detecção do comprometimento muscular
clinicamente ativo em pacientes com dermatomiosite.
PALAVRAS-CHAVE: Dermatomiosite. Lupus Eritematoso Sistêmico.
Comprometimento muscular. Crianças. Ressonância Magnética.
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